BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26459920)

  • 1. Analysis of the direct injury effector of oligodendroglia cells or myelin sheath in an experimental allergic encephalomyelitis model induced by the MOG35-55 peptide.
    Zhou X; Li X; Feng M; Zhang Q; Yang Z
    Mol Med Rep; 2015 Nov; 12(5):7425-32. PubMed ID: 26459920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.
    Crocker SJ; Whitmire JK; Frausto RF; Chertboonmuang P; Soloway PD; Whitton JL; Campbell IL
    Am J Pathol; 2006 Dec; 169(6):2104-16. PubMed ID: 17148673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant.
    Jagessar SA; Heijmans N; Blezer EL; Bauer J; Weissert R; 't Hart BA
    J Neuroinflammation; 2015 Sep; 12():169. PubMed ID: 26377397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.
    Evonuk KS; Baker BJ; Doyle RE; Moseley CE; Sestero CM; Johnston BP; De Sarno P; Tang A; Gembitsky I; Hewett SJ; Weaver CT; Raman C; DeSilva TM
    J Immunol; 2015 Jul; 195(2):450-463. PubMed ID: 26071560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
    Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.
    Teige A; Teige I; Lavasani S; Bockermann R; Mondoc E; Holmdahl R; Issazadeh-Navikas S
    J Immunol; 2004 Jan; 172(1):186-94. PubMed ID: 14688325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.
    Delarasse C; Daubas P; Mars LT; Vizler C; Litzenburger T; Iglesias A; Bauer J; Della Gaspera B; Schubart A; Decker L; Dimitri D; Roussel G; Dierich A; Amor S; Dautigny A; Liblau R; Pham-Dinh D
    J Clin Invest; 2003 Aug; 112(4):544-53. PubMed ID: 12925695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice.
    Malipiero U; Frei K; Spanaus KS; Agresti C; Lassmann H; Hahne M; Tschopp J; Eugster HP; Fontana A
    Eur J Immunol; 1997 Dec; 27(12):3151-60. PubMed ID: 9464800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell recognition of myelin oligodendrocyte glycoprotein autoantigen depends on immunization with protein rather than short peptide, while B cell invasion of the CNS in autoimmunity does not.
    Dang AK; Jain RW; Craig HC; Kerfoot SM
    J Neuroimmunol; 2015 Jan; 278():73-84. PubMed ID: 25595255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
    Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
    Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
    J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
    Bhasin M; Wu M; Tsirka SE
    BMC Immunol; 2007 Jul; 8():10. PubMed ID: 17634104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
    Papaneophytou CP; Georgiou E; Karaiskos C; Sargiannidou I; Markoullis K; Freidin MM; Abrams CK; Kleopa KA
    Glia; 2018 Dec; 66(12):2589-2603. PubMed ID: 30325069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas has a crucial role in the progression of experimental autoimmune encephalomyelitis.
    Okuda Y; Bernard CC; Fujimura H; Yanagihara T; Sakoda S
    Mol Immunol; 1998 Apr; 35(5):317-26. PubMed ID: 9747891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glial 14-3-3 gamma protein in autoimmune demyelination.
    Lee DH; Steinacker P; Seubert S; Turnescu T; Melms A; Manzel A; Otto M; Linker RA
    J Neuroinflammation; 2015 Oct; 12():187. PubMed ID: 26438180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.